.
BioEnterprise

FDA Designation “Really Big Deal” for Athersys

Athersys‘ clinical trial program for stroke receives the U.S. Food & Drug Administration “Fast Track Designation,” an expedited drug development and review program for new drugs or biologics to treat serious or life-threatening conditions.

Read More  >
Hello. Add your message here.